Studies on the extra-mitochondrial CoA -ester formation of valproic and Delta4 -valproic acids.

[1]  J. Cronan,et al.  The soluble acyl-acyl carrier protein synthetase of Vibrio harveyi B392 is a member of the medium chain acyl-CoA synthetase family. , 2006, Biochemistry.

[2]  K. Igarashi,et al.  Purification, characterization, and mass spectrometric sequencing of a medium chain acyl-CoA synthetase from mouse liver mitochondria and comparisons with the homologues of rat and bovine. , 2006, Protein expression and purification.

[3]  P. Watkins,et al.  Comparative Biochemical Studies of the Murine Fatty Acid Transport Proteins (FATP) Expressed in Yeast* , 2005, Journal of Biological Chemistry.

[4]  D. Bernlohr,et al.  Enzymatic Properties of Purified Murine Fatty Acid Transport Protein 4 and Analysis of Acyl-CoA Synthetase Activities in Tissues from FATP4 Null Mice* , 2005, Journal of Biological Chemistry.

[5]  C. Rock,et al.  Coenzyme A: back in action. , 2005, Progress in lipid research.

[6]  I. T. de Almeida,et al.  Valproyl-dephosphoCoA: a novel metabolite of valproate formed in vitro in rat liver mitochondria. , 2004, Drug metabolism and disposition: the biological fate of chemicals.

[7]  Lois J. Maltais,et al.  Revised nomenclature for the mammalian long-chain acyl-CoA synthetase gene family Published, JLR Papers in Press, August 1, 2004. DOI 10.1194/jlr.E400002-JLR200 , 2004, Journal of Lipid Research.

[8]  Tetsuya Hori,et al.  Structural Basis of the Substrate-specific Two-step Catalysis of Long Chain Fatty Acyl-CoA Synthetase Dimer* , 2004, Journal of Biological Chemistry.

[9]  G. Gerber,et al.  Biochemical Demonstration of the Involvement of Fatty Acyl-CoA Synthetase in Fatty Acid Translocation across the Plasma Membrane* , 2004, Journal of Biological Chemistry.

[10]  W. Stremmel,et al.  New concepts of cellular fatty acid uptake: role of fatty acid transport proteins and of caveolae , 2004, The Proceedings of the Nutrition Society.

[11]  S. Eaton,et al.  Mitochondrial beta-oxidation. , 2004, European journal of biochemistry.

[12]  D. Pessayre,et al.  Hepatotoxicity due to mitochondrial dysfunction , 2004, Cell Biology and Toxicology.

[13]  D. Bernlohr,et al.  Characterization of the Acyl-CoA Synthetase Activity of Purified Murine Fatty Acid Transport Protein 1* , 2003, Journal of Biological Chemistry.

[14]  R. Warren,et al.  Isolation, sequencing, and expression of a cDNA for the HXM‐A form of xenobiotic/medium‐chain fatty acid:CoA ligase from human liver mitochondria , 2003, Journal of biochemical and molecular toxicology.

[15]  A. Verkman,et al.  Diffusion of Tricarboxylic Acid Cycle Enzymes in the Mitochondrial Matrix in Vivo , 2002, The Journal of Biological Chemistry.

[16]  R. Wanders,et al.  Complete beta-oxidation of valproate: cleavage of 3-oxovalproyl-CoA by a mitochondrial 3-oxoacyl-CoA thiolase. , 2002, The Biochemical journal.

[17]  I. T. de Almeida,et al.  Differential effect of valproate and its Delta2- and Delta4-unsaturated metabolites, on the beta-oxidation rate of long-chain and medium-chain fatty acids. , 2001, Chemico-biological interactions.

[18]  S. Takahashi,et al.  Molecular Identification and Characterization of Two Medium-chain Acyl-CoA Synthetases, MACS1 and the Sa Gene Product* , 2001, The Journal of Biological Chemistry.

[19]  T. M. Lewin,et al.  Acyl-CoA Synthetase Isoforms 1, 4, and 5 Are Present in Different Subcellular Membranes in Rat Liver and Can Be Inhibited Independently* , 2001, The Journal of Biological Chemistry.

[20]  R. Wanders,et al.  Synthesis and intramitochondrial levels of valproyl-coenzyme A metabolites. , 2001, Analytical biochemistry.

[21]  P. Watkins,et al.  Very Long-chain Acyl-CoA Synthetases , 2000, The Journal of Biological Chemistry.

[22]  K. Knights,et al.  Xenobiotic-CoA ligases: kinetic and molecular characterization. , 2000, Current drug metabolism.

[23]  K. Igarashi,et al.  Characterization of a renal medium chain acyl-CoA synthetase responsible for glycine conjugation in mouse kidney mitochondria. , 1999, Chemico-biological interactions.

[24]  K. Knights.  ROLE OF HEPATIC FATTY ACID:COENZYME A LIGASES IN THE METABOLISM OF XENOBIOTIC CARBOXYLIC ACIDS , 1998, Clinical and experimental pharmacology & physiology.

[25]  P. Watkins.  Fatty acid activation. , 1997, Progress in lipid research.

[26]  K. Nokihara,et al.  Purification and characterization of a medium chain acyl-coenzyme A synthetase. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[27]  D. Pessayre,et al.  Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. , 1995, Pharmacology & therapeutics.

[28]  H. Schulz,et al.  The relationship between mitochondrial activation and toxicity of some substituted carboxylic acids. , 1994, Chemico-biological interactions.

[29]  F. Van hoof,et al.  In vitro effects of valproate and valproate metabolites on mitochondrial oxidations. Relevance of CoA sequestration to the observed inhibitions. , 1992, Biochemical pharmacology.

[30]  D. Norwood,et al.  Mitochondrial metabolism of valproic acid. , 1991, Biochemistry.

[31]  K. Moore,et al.  Hepatic hydrolysis of octanoyl-CoA and valproyl-CoA in control and valproate-fed animals. , 1988, The International journal of biochemistry.

[32]  T. Baillie,et al.  Studies on the biotransformation in the perfused rat liver of 2-n-propyl-4-pentenoic acid, a metabolite of the antiepileptic drug valproic acid. Evidence for the formation of chemically reactive intermediates. , 1985, Drug metabolism and disposition: the biological fate of chemicals.

[33]  G. Granneman,et al.  The Hepatotoxicity of Valproic Acid and Its Metabolites in Rats. I. Toxicologic, Biochemical and Histopathologic Studies , 1984, Hepatology.

[34]  Robert A. Harris,et al.  Influence of valproic acid on hepatic carbohydrate and lipid metabolism. , 1983, Archives of biochemistry and biophysics.

[35]  D. Friend,et al.  HIGH-YIELD PREPARATION OF ISOLATED RAT LIVER PARENCHYMAL CELLS , 1969, Journal of Cell Biology.